Rxo (RXO) Operating Income (2021 - 2025)
Historic Operating Income for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to -$42.0 million.
- Rxo's Operating Income fell 7500.0% to -$42.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$79.0 million, marking a year-over-year decrease of 4107.14%. This contributed to the annual value of -$79.0 million for FY2025, which is 4107.14% down from last year.
- According to the latest figures from Q4 2025, Rxo's Operating Income is -$42.0 million, which was down 7500.0% from -$7.0 million recorded in Q3 2025.
- Rxo's Operating Income's 5-year high stood at $58.0 million during Q2 2022, with a 5-year trough of -$42.0 million in Q4 2025.
- Its 5-year average for Operating Income is $7.5 million, with a median of $5.5 million in 2023.
- In the last 5 years, Rxo's Operating Income soared by 150000.0% in 2023 and then crashed by 43333.33% in 2024.
- Quarter analysis of 5 years shows Rxo's Operating Income stood at $55.0 million in 2021, then plummeted by 101.82% to -$1.0 million in 2022, then surged by 1500.0% to $14.0 million in 2023, then tumbled by 271.43% to -$24.0 million in 2024, then crashed by 75.0% to -$42.0 million in 2025.
- Its Operating Income stands at -$42.0 million for Q4 2025, versus -$7.0 million for Q3 2025 and -$30.0 million for Q1 2025.